Research Peptides
A high-purity research peptide studied in libido research. Available in 10mg, with every batch independently tested and dispatched from the UK.
A high-purity research peptide studied in libido research. Available in 10mg, with every batch independently tested and dispatched from the UK.
PT-141 peptide UK is Crown Peptides' synthetic cyclic melanocortin peptide (bremelanotide), supplied in 10mg vials for laboratory research into melanocortin receptor pharmacology and central nervous system signalling.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
PT-141, also known as bremelanotide, is a synthetic cyclic melanocortin peptide derived from melanocortin research. Unlike pigmentation-focused analogues, much of its mechanistic research centres on central melanocortin receptor pathways.
PT-141 is studied in melanocortin receptor pharmacology, particularly pathways involving MC3R and MC4R in the central nervous system (Learn more). Experimental models examine neural signalling, autonomic responses and behavioural neurobiology associated with melanocortin-system activation, alongside related melanocortin-research peptides such as [Melanotan-1] and [Melanotan-2]. Its research profile demonstrates how related melanocortin peptides can produce different biological responses depending on receptor preference and tissue context.
Compound-level reference data. Batch-specific results appear on the Certificate of Analysis.
Work out concentration with the peptide calculatorCrown Peptides PT-141 is supplied for controlled laboratory research with batch-specific analytical documentation. High-Performance Liquid Chromatography (HPLC) can assess chromatographic purity, while Mass Spectrometry provides molecular information used to support identity verification. The batch-specific Certificate of Analysis is the definitive source for the exact purity result, identity data and analytical specification of the material supplied.
Researchers working with PT-141 may also be interested in [Melanotan-1], [Melanotan-2], [Kisspeptin-10], [GHK-Cu] and [KPV] — other melanocortin and receptor-signalling peptides studied in related research areas.
PT-141 is a synthetic cyclic melanocortin peptide also known as bremelanotide, supplied by Crown Peptides in 10mg vials.
Research focuses strongly on central melanocortin receptors, including MC3R and MC4R-related signalling.
Its research profile centres more heavily on central melanocortin signalling rather than primarily on MC1R-driven melanogenesis.
Experimental studies include melanocortin receptor pharmacology, central nervous system signalling and behavioural neurobiology.
Peptide purity and molecular identity can be assessed using HPLC and Mass Spectrometry, with batch-specific results documented on the CoA.
Every batch is published openly — identity, purity and batch number, with no account needed.
Supplied for laboratory research purposes only — not for human consumption or for medical, veterinary or diagnostic use.
Each batch undergoes internal analytical verification using chromatographic and spectrometric methods prior to lyophilisation.
• HPLC Analysis
• Mass Spectrometry Confirmation
• Batch Traceability
By purchasing this product you confirm that you are a qualified researcher and that this compound will be used exclusively for laboratory research purposes.
This product is not intended for diagnostic or therapeutic use.
Any human or medical use is strictly prohibited.
Store in a cool, dry, secure and sterile environment away from any unauthorised persons or children.
Disclaimer: All products are sold strictly for laboratory research purposes only. Not for human or veterinary use, consumption, therapeutic, or diagnostic application. By purchasing, you confirm you are a qualified professional and legally permitted to handle these materials in compliance with all applicable laws and regulations. Misuse, resale for unauthorised purposes, or unlawful application is strictly prohibited. Crown Peptides UK disclaims all liability for improper use, handling, or regulatory non-compliance.